simurosertib (TAK-931) / Takeda, ZAI Lab  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
simurosertib (TAK-931) / Takeda, ZAI Lab
NCT03708211: A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors

Completed
1
20
Europe
TAK-931 PIC, TAK-931 Tablet, Esomeprazole
Millennium Pharmaceuticals, Inc.
Neoplasms, Advanced Solid
12/19
12/19
NCT02699749: A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors

Completed
1
80
Japan
TAK-931
Millennium Pharmaceuticals, Inc.
Nonhematologic Neoplasms, Advanced
12/19
12/19

Download Options